BioNexus Gene Lab Corp. (BGLC) vs INLIF Limited (INLF)
A side-by-side comparison of BioNexus Gene Lab Corp. and INLIF Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.24IndustrialsDelayed quote: Oct 6, 2026, 4:00 PM EDT
INLF
INLIF Limited
$3.44IndustrialsDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BGLC vs INLF
growth of $100 · dividends reinvested · last 2yBGLC -67.9% (-43.4%/yr)INLF -100.0% (-98.5%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
BGLC INLF
BGLC vs INLF: by the numbers
- •INLF is the larger company ($4M vs $3M market cap).
- •Both run net losses; INLF's is the smaller (-29.59% vs -82.36% net margin).
Metrics side by side
Valuation
| Metric | BGLC | INLF |
|---|---|---|
| P/S ratio | 0.96 | N/A |
| P/B ratio | 0.39 | 0.05 |
Profitability
| Metric | BGLC | INLF |
|---|---|---|
| Gross margin | 11.64% | 23.33% |
| Operating margin | -42.54% | -31.60% |
| Net margin | -82.36% | -29.59% |
| ROE | -33.11% | -33.75% |
| ROIC | -32.71% | -28.01% |
Growth (annualized)
| Metric | BGLC | INLF |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | N/A |
| Total return CAGR (5Y) | -61.00% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.